Comparison of Hodgkin’s Lymphoma in Children and Adolescents. A Twenty Year Experience with MH’96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols

Adolescents and young adults (AYAs) represent a distinct group of patients. The objectives of this study were: To compare adolescent prognosis to that of younger children; to compare the results achieved with the two consecutive protocols in both age groups; to analyze clinical characteristics of children and adolescents. Between 1996 and 2017, 1759 patients aged <18 years were evaluable for the study. Five hundred and sixty patients were treated with the MH’96 protocol and 1199 with the LH2004 protocol. Four hundred and eighty-two were adolescents aged ≥15 years. Patients in both age groups showed very favorable prognoses. In particular, OS improved with the LH2004 protocol, especially in the adolescent group and in the low risk group, where radiation therapy was spared. Adolescent characteristics differed significantly from the children’s according to sex, histology, and the presence of symptoms. Remarkable is the decrease both in mixed cellularity in the children and in low stages in both age groups in the LH2004 protocol with respect to MH’96 protocol. Based on our experience, adopting pediatric protocols for AYA does not compromise patient outcomes.

[1]  P. Nathan,et al.  Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study , 2020, Cancer medicine.

[2]  G. Defossez,et al.  Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival. , 2020, Journal of adolescent and young adult oncology.

[3]  F. Bertucci,et al.  Adolescents and young adults with classical Hodgkin lymphoma in North Tunisia: Insights from an adult single-institutional study. , 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[4]  J. Coebergh,et al.  Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study during 1990–2015 , 2020, British journal of haematology.

[5]  G. Salles,et al.  Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region. , 2019, Journal of adolescent and young adult oncology.

[6]  M. Maule,et al.  Evolving Services for Adolescents with Cancer in Italy: Access to Pediatric Oncology Centers and Dedicated Projects. , 2019, Journal of adolescent and young adult oncology.

[7]  K. Ballantine,et al.  An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA? , 2019, Journal of adolescent and young adult oncology.

[8]  J. Kruseová,et al.  Accelerated atherosclerosis, hyperlipoproteinemia and insulin resistance in long-term survivors of Hodgkin lymphoma during childhood and adolescence. , 2019, Neoplasma.

[9]  P. Kamper,et al.  Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors—A population‐based cohort study from Sweden and Denmark , 2019, Cancer medicine.

[10]  M. Ward,et al.  Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population–based study , 2019, Cancer.

[11]  J. Zaucha,et al.  The role of PET/CT in the modern treatment of Hodgkin lymphoma. , 2019, Cancer treatment reviews.

[12]  A. Olshan,et al.  Noncancer mortality among adolescents and young adults with cancer , 2019, Cancer.

[13]  Lindsay A. Williams,et al.  Sex ratio among childhood cancers by single year of age , 2019, Pediatric blood & cancer.

[14]  Yi-Lin Wu,et al.  Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma , 2019, Cancer.

[15]  A. LaCasce,et al.  Current considerations in AYA Hodgkin lymphoma , 2018, British journal of haematology.

[16]  L. Guerra,et al.  FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  C. Flowers,et al.  Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States , 2018, British journal of haematology.

[18]  L. Guerra,et al.  Italian Multicenter Study on Accuracy of 18F‐FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma , 2018, Clinical lymphoma, myeloma & leukemia.

[19]  D. Salmerón,et al.  Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years , 2018, Clinical and Translational Oncology.

[20]  R. Ambinder,et al.  Hodgkin lymphoma: A review and update on recent progress , 2018, CA: a cancer journal for clinicians.

[21]  S. Pileri,et al.  Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy , 2018, Leukemia & lymphoma.

[22]  J. Taub,et al.  Excess mortality among 10‐year survivors of classical Hodgkin lymphoma in adolescents and young adults , 2018, American journal of hematology.

[23]  T. Fitzgerald,et al.  Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy , 2018, Clinical Medicine Insights. Oncology.

[24]  L. Constine,et al.  Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response‐based chemotherapy on pediatric protocols: A Children's Oncology Group report , 2017, Pediatric blood & cancer.

[25]  L. Quéro,et al.  Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients , 2017, Oncotarget.

[26]  P. Kamper,et al.  Hodgkin lymphoma in children, adolescents and young adults – a comparative study of clinical presentation and treatment outcome , 2017, Acta oncologica.

[27]  A. Ng,et al.  Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. , 2016, Hematology. American Society of Hematology. Education Program.

[28]  H. Karim-Kos,et al.  Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011. , 2016, Cancer epidemiology.

[29]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[30]  A. Bleyer,et al.  Cancer in Adolescents and Young Adults: A Narrative Review of the Current Status and a View of the Future. , 2016, JAMA pediatrics.

[31]  L. Ries,et al.  Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults , 2016, Cancer.

[32]  M. Maule,et al.  Adolescents with Cancer in Italy: Improving Access to National Cooperative Pediatric Oncology Group (AIEOP) Centers , 2016, Pediatric blood & cancer.

[33]  C. Stiller,et al.  Survival patterns in teenagers and young adults with cancer in the United Kingdom: Comparisons with younger and older age groups. , 2015, European journal of cancer.

[34]  D. Weisenburger,et al.  Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice? , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[35]  T. Fitzgerald,et al.  The Impact of Protocol Assignment for Older Adolescents with Hodgkin Lymphoma , 2014, Front. Oncol..

[36]  A. Engert,et al.  The Challenging Aspects of Managing Adolescents and Young Adults with Hodgkin's Lymphoma , 2014, Acta Haematologica.

[37]  C. Stiller,et al.  Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. , 2011, JAMA.

[38]  Á. Illés,et al.  Adolescent Hodgkin Lymphoma: Are Treatment Results More Favorable With Pediatric Than With Adult Regimens? , 2011, Journal of pediatric hematology/oncology.

[39]  W. Klapper,et al.  Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  A. Whittemore,et al.  Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  H. Eich,et al.  Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  A. Ferrari,et al.  Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials. , 2009, European journal of cancer.

[43]  K. Kelly,et al.  Adolescent non‐Hodgkin lymphoma and Hodgkin lymphoma: state of the science , 2009, British journal of haematology.

[44]  M. Geraci,et al.  Survival from cancer in teenagers and young adults in England, 1979–2003 , 2008, British Journal of Cancer.

[45]  R. Herbertson,et al.  Poor outcome in adolescents with high-risk Hodgkin lymphoma. , 2008, International journal of oncology.

[46]  C. Stiller.  International patterns of cancer incidence in adolescents. , 2007, Cancer treatment reviews.

[47]  T. Economopoulos,et al.  Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades. , 2007, Anticancer research.

[48]  G. Morgan,et al.  Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy , 2007, Cancer Epidemiology Biomarkers & Prevention.

[49]  A. Bleyer,et al.  Adolescents and young adults with cancer , 2006, Cancer.

[50]  E. Steliarova-Foucher,et al.  Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the Automated Cancer Information System project. , 2006, European journal of cancer.

[51]  J. Connors,et al.  Hodgkin's lymphoma in adolescents. , 2006, Journal of Clinical Oncology.

[52]  P. Hoskin,et al.  Long Term Outcome in Adolescents with Hodgkin's Lymphoma: Poor Results using Regimens Designed for Adults , 2004, Leukemia & lymphoma.

[53]  H. Bartelink,et al.  Long-term cause-specific mortality of patients treated for Hodgkin's disease. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[55]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[56]  C. Schwartz.  The management of Hodgkin disease in the young child , 2003, Current opinion in pediatrics.

[57]  V. Diehl,et al.  Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  V. Diehl,et al.  [German Hodgkin's Lymphoma Study Group]. , 2001, Onkologie.

[59]  G. Leverger,et al.  Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  R. Pötter,et al.  High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  F. Behm,et al.  Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  J. Andrieu,et al.  Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  J. Herson.  The statistical analysis of failure time data , 1981 .

[64]  A S Halpern,et al.  Nonmarital Cohabitation, Marriage, and Health Among Adolescents and Young Adults , 2013 .

[65]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[66]  R. Advani,et al.  Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis , 2018, Cancer.

[67]  D. Costarelli,et al.  Italian cancer figures, report 2012: Cancer in children and adolescents. , 2013, Epidemiologia e prevenzione.

[68]  L. Rodríguez,et al.  Hodgkin’s Lymphoma in Adolescents and Young Adults , 2012 .

[69]  D. Taddeo,et al.  Adherence to treatment in adolescents. , 2008, Paediatrics & child health.

[70]  A. Bleyer,et al.  Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. , 2006 .